이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2002. 10. 24.1 분 읽기
Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEPREX; Amendment
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is amending a previous determination of the regulatory review period for MIFEPREX that appeared in the Federal Register of January 25, 2002 (67 FR 3724). The agency is taking this action in response to received comments. FDA is publishing notice of that amendment as required by law.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →